The blockbuster weight loss drug Wegovy is now approved in the U.S. for heart health. But some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say ...
In the U.S., Wegovy is no longer just for weight loss. Stream San Diego News for free, 24/7, wherever you are with NBC 7. Some employers and other health plans are still reluctant to cover Wegovy due ...
Prudential Financial, Inc. (NYSE:PRU) is included among the Best Stocks for a Dividend Achievers List. On December 16, Mizuho analyst Yaron Kinar initiated coverage of Prudential Financial, Inc. (NYSE ...
On December 16, Mizuho analyst Yaron Kinar initiated coverage of Prudential Financial, Inc. (NYSE:PRU) with a Neutral rating and a $125 price target. The initiation was part of a broader launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback